C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/4355 (2006.01) A61K 31/437 (2006.01) A61K 31/4375 (2006.01) C07D 498/04 (2006.01)
Patent
CA 2562138
A compound having the general structure shown in Formula (1) or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
Composé de structure générale représenté par la formule (I) ou sels pharmaceutiquement acceptables et/ou solvates de ce composé, convenant pour le traitement de pathologies ou d'états induits par des récepteurs NK1 tels que divers troubles physiologiques, symptômes ou maladies dont les vomissements, la dépression, l'anxiété ou la toux.
Palani Anandan
Reichard Gregory A.
Shih Neng-Yang
Tsui Hon-Chung
Wang Cheng
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Fused ring nk1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused ring nk1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused ring nk1 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2006884